Cationic lipids enhance siRNA-mediated interferon response in mice

Biochemical and Biophysical Research Communications

Volumn 330, Issue 3, 2005, Pages 755-759

  Ma, Zheng ^a   Li, Jiang ^a   He, Fengtian ^a   Wilson, Annette ^b   Pitt, Bruce ^b   Li, Song ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cationic liposome; Innate immunity; Interferon response; RNA interference; siRNA

Indexed keywords

1,2 DIOLEOYL 3 TRIMETHYLAMMONIOPROPANE; INTERFERON; LIPOSOME; SMALL INTERFERING RNA; STAT1 PROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COMPLEX FORMATION; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNE RESPONSE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN INDUCTION; RNA INTERFERENCE; TRANSCRIPTION INITIATION; WESTERN BLOTTING;

EID: 16244362066     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbrc.2005.03.041     Document Type: Article

References (25)

1. S.M. Elbashir, J. Harborth, W. Lendeckel, A. Yalcin, K. Weber, and T. Tuschl Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells Nature 411 2001 494 498
2. K.V. Morris, S.W. Chan, S.E. Jacobsen, and D.J. Looney Small interfering RNA-induced transcriptional gene silencing in human cells Science 305 2004 1289 1292
3. H. Kawasaki, and K. Taira Induction of DNA methylation and gene silencing by short interfering RNAs in human cells Nature 431 2004 211 217
4. C.A. Sledz, M. Holko, M.J. de Veer, R.H. Silverman, and B.R. Williams Activation of the interferon system by short-interfering RNAs Nat. Cell Biol. 5 2003 834 839
5. A.J. Bridge, S. Pebernard, A. Ducraux, A.L. Nicoulaz, and R. Iggo Induction of an interferon response by RNAi vectors in mammalian cells Nat. Genet. 34 2003 263 264
6. K. Kariko, P. Bhuyan, J. Capodici, and D. Weissman Small interfering RNAs mediate sequence-independent gene suppression and induce immune activation by signaling through toll-like receptor 3 J. Immunol. 172 2004 6545 6549
7. A.L. Jackson, S.R. Bartz, J. Schelter, S.V. Kobayashi, J. Burchard, M. Mao, B. Lii, G. Cavet, and P.S. Linsley Expression profiling reveals off-target gene regulation by RNA Nat. Biotechnol. 21 2003 635 637
8. P.C. Scacheri, O. Rozenblatt-Rosen, N.J. Caplen, T.G. Wolfsberg, L. Umayam, J.C. Lee, C.M. Hughes, K.S. Shanmugam, A. Bhattacharjee, M. Meyerson, and F.S. Collins Short interfering RNAs can induce unexpected and divergent changes in the levels of untargeted proteins in mammalian cells Proc. Natl. Acad. Sci. USA 101 2004 1892 1897
9. J.D. Heidel, S. Hu, X.F. Liu, T.J. Triche, and M.E. Davis Lack of interferon response in animals to naked siRNAs Nat. Biotechnol. 22 2004 1579 1582
10. M.M. Whitmore, S. Li, L. Falo Jr., and L. Huang Systemic administration of LPD prepared with CpG oligonucleotides inhibits the growth of established pulmonary metastases by stimulating innate and acquired antitumor immune responses Cancer Immunol. Immunother. 50 2001 503 514
11. Y. Tan, S. Li, B.R. Pitt, and L. Huang The inhibitory role of CpG immunostimulatory motifs in cationic lipid vector-mediated transgene expression in vivo Hum. Gene Ther. 10 1999 2153 2161
12. + T cells J. Immunol. 167 2001 6462 6470
13. Y. Suzuki, D. Wakita, K. Chamoto, Y. Narita, T. Tsuji, T. Takeshima, H. Gyobu, Y. Kawarada, S. Kondo, S. Akira, H. Katoh, H. Ikeda, and T. Nishimura Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity Cancer Res. 64 2004 8754 8760
14. J.E. Durbin, R. Hackenmiller, M.C. Simon, and D.E. Levy Targeted disruption of the mouse Stat1 gene results in compromised innate immunity to viral disease Cell 84 1996 443 450
15. M.A. Meraz, J.M. White, K.C. Sheehan, E.A. Bach, S.J. Rodig, A.S. Dighe, D.H. Kaplan, J.K. Riley, A.C. Greenlund, D. Campbell, K. Carver-Moore, R.N. DuBois, R. Clark, M. Aguet, and R.D. Schreiber Targeted disruption of the Stat1 gene in mice reveals unexpected physiologic specificity in the JAK-STAT signaling pathway Cell 84 1996 431 442
16. S. Li, Y. Tan, E. Viroonchatapan, B.R. Pitt, and L. Huang Targeted gene delivery to pulmonary endothelium by anti-PECAM antibody Am. J. Physiol. Lung Cell. Mol. Physiol. 278 2000 L504 L511
17. T. Taniguchi, and A. Takaoka A weak signal for strong responses: interferon-alpha/beta revisited Nat. Rev. Mol. Cell Biol. 2 2001 378 386
18. V. Hornung, M. Guenthner-Biller, C. Bourquin, A. Ablasser, M. Schlee, S. Uematsu, A. Noronha, M. Manoharan, S. Akira, A. de Fougerolles, S. Endres, and G. Hartmann Sequence-specific potent induction of IFN-alpha by short interfering RNA in plasmacytoid dendritic cells through TLR7 Nat. Med. 20 2005 [Epub ahead of print]
19. Y. Liu, L.C. Mounkes, H.D. Liggitt, C.S. Brown, I. Solodin, T.D. Heath, and R.J. Debs Factors influencing the efficiency of cationic liposome-mediated intravenous gene delivery Nat. Biotechnol. 15 1997 167 173
20. Y.K. Song, F. Liu, S. Chu, and D. Liu Characterization of cationic liposome-mediated gene transfer in vivo by intravenous administration Hum. Gene Ther. 8 1997 1585 1594
21. L.G. Barron, K.B. Meyer, and F.C. Szoka Jr. Effects of complement depletion on the pharmacokinetics and gene delivery mediated by cationic lipid-DNA complexes Hum. Gene Ther. 9 1998 315 323
22. S. Li, and L. Huang In vivo gene transfer via intravenous administration of cationic lipid-protamine-DNA (LPD) complexes Gene Ther. 4 1997 891 900
23. Z. Ma, J. Zhang, S. Alber, J. Dileo, Y. Negishi, D. Stolz, S. Watkins, L. Huang, B. Pitt, and S. Li Lipid-mediated delivery of oligonucleotide to pulmonary endothelium Am. J. Respir. Cell Mol. Biol. 27 2002 151 159
24. G.B. Lipford, T. Sparwasser, M. Bauer, S. Zimmermann, E.S. Koch, K. Heeg, and H. Wagner Immunostimulatory DNA: sequence-dependent production of potentially harmful or useful cytokines Eur. J. Immunol. 27 1997 3420 3426
25. M.M. Whitmore, M.J. DeVeer, A. Edling, R.K. Oates, B. Simons, D. Lindner, and B.R. Williams Synergistic activation of innate immunity by double-stranded RNA and CpG DNA promotes enhanced antitumor activity Cancer Res. 64 2004 5850 5860